1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP2K3 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO Map2k3 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of MAP2K3 mRNA CTD PMID:20551477 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of MAP2K3 mRNA CTD PMID:15598610 17beta-estradiol increases expression ISO MAP2K3 (Homo sapiens) 6480464 Estradiol results in increased expression of MAP2K3 mRNA CTD PMID:31614463 17beta-estradiol decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Estradiol results in decreased expression of MAP2K3 mRNA CTD PMID:23094148 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP2K3 mRNA CTD PMID:18796159 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP2K3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K3 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression ISO Map2k3 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of MAP2K3 mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO MAP2K3 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of MAP2K3 mRNA CTD PMID:37199045 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of MAP2K3 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K3 protein] CTD PMID:16407847 4-hydroxyphenyl retinamide increases phosphorylation ISO MAP2K3 (Homo sapiens) 6480464 Fenretinide results in increased phosphorylation of MAP2K3 protein CTD PMID:16407847 9-cis,11-trans-octadecadienoic acid multiple interactions ISO Map2k3 (Rattus norvegicus) 6480464 [cis-9 more ... CTD PMID:17869086 afimoxifene decreases response to substance ISO MAP2K3 (Homo sapiens) 6480464 MAP2K3 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of MAP2K3 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO MAP2K3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of MAP2K3 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO MAP2K3 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of MAP2K3 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO MAP2K3 (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP2K3 mRNA CTD PMID:33167477 AM-251 decreases expression ISO MAP2K3 (Homo sapiens) 6480464 AM 251 results in decreased expression of MAP2K3 mRNA CTD PMID:16500647 aristolochic acid A increases expression ISO MAP2K3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of MAP2K3 mRNA CTD PMID:33212167 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of MAP2K3 mRNA CTD PMID:18191166 arsenous acid increases expression ISO MAP2K3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP2K3 mRNA CTD PMID:29633893 arsenous acid multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein] and Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein CTD PMID:16818652 and PMID:20615082 arsenous acid affects response to substance EXP 6480464 MAP2K3 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 arsenous acid multiple interactions EXP 6480464 MAP2K3 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 Azaspiracid decreases expression ISO MAP2K3 (Homo sapiens) 6480464 azaspiracid results in decreased expression of MAP2K3 mRNA CTD PMID:28939011 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAP2K3 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO MAP2K3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MAP2K3 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO MAP2K3 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide increases phosphorylation ISO MAP2K3 (Homo sapiens) 6480464 Mustard Gas results in increased phosphorylation of MAP2K3 protein CTD PMID:15251176 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP2K3 mRNA and bisphenol A results in increased expression of MAP2K3 protein CTD PMID:26996129 and PMID:33221593 bisphenol A increases expression ISO Map2k3 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of MAP2K3 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO MAP2K3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of MAP2K3 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA CTD PMID:28628672 bisphenol A affects expression ISO Map2k3 (Rattus norvegicus) 6480464 bisphenol A affects the expression of MAP2K3 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of ADIPOQ mRNA]] more ... CTD PMID:26996129 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of MAP2K3 mRNA CTD PMID:30951980 butanal increases expression ISO MAP2K3 (Homo sapiens) 6480464 butyraldehyde results in increased expression of MAP2K3 mRNA CTD PMID:26079696 cadmium dichloride multiple interactions ISO Map2k3 (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein] CTD PMID:18703135 cadmium dichloride increases phosphorylation ISO MAP2K3 (Homo sapiens) 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K3 protein CTD PMID:18703135 cadmium dichloride multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein] CTD PMID:18703135 cadmium dichloride increases expression ISO MAP2K3 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP2K3 mRNA CTD PMID:12160620 and PMID:32512071 cadmium dichloride increases phosphorylation ISO Map2k3 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K3 protein CTD PMID:18021293 and PMID:18703135 camptothecin increases expression ISO MAP2K3 (Homo sapiens) 6480464 Camptothecin results in increased expression of MAP2K3 mRNA CTD PMID:17374387 carbamazepine affects expression ISO MAP2K3 (Homo sapiens) 6480464 Carbamazepine affects the expression of MAP2K3 mRNA CTD PMID:24752500 carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon analog results in increased expression of MAP2K3 mRNA CTD PMID:25554681 cisplatin increases response to substance ISO MAP2K3 (Homo sapiens) 6480464 MAP2K3 results in increased susceptibility to Cisplatin CTD PMID:22164285 cisplatin multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MAP2K3 mRNA CTD PMID:27392435 clofibric acid multiple interactions ISO Map2k3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP2K3 mRNA CTD PMID:17602206 cobalt dichloride increases expression ISO Map2k3 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of MAP2K3 mRNA CTD PMID:24386269 copper atom multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP2K3 mRNA and [Disulfiram binds to Copper] which results in decreased expression of MAP2K3 mRNA CTD PMID:24690739 and PMID:30911355 copper(0) multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP2K3 mRNA and [Disulfiram binds to Copper] which results in decreased expression of MAP2K3 mRNA CTD PMID:24690739 and PMID:30911355 corn oil increases expression EXP 6480464 Corn Oil results in increased expression of MAP2K3 mRNA CTD PMID:33263755 coumestrol decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Coumestrol results in decreased expression of MAP2K3 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO MAP2K3 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of MAP2K3 mRNA CTD PMID:17331233 crocidolite asbestos increases expression ISO MAP2K3 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of MAP2K3 mRNA CTD PMID:18687144 curcumin increases expression ISO MAP2K3 (Homo sapiens) 6480464 Curcumin results in increased expression of MAP2K3 mRNA CTD PMID:15713895 cyclosporin A decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MAP2K3 mRNA CTD PMID:20106945 daunorubicin increases expression ISO MAP2K3 (Homo sapiens) 6480464 Daunorubicin results in increased expression of MAP2K3 mRNA CTD PMID:17374387 dexamethasone increases expression ISO MAP2K3 (Homo sapiens) 6480464 Dexamethasone results in increased expression of MAP2K3 mRNA CTD PMID:15817653 dexamethasone multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions EXP 6480464 MAP2K3 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 diarsenic trioxide multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein] and Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein CTD PMID:16818652 and PMID:20615082 diarsenic trioxide increases expression ISO MAP2K3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP2K3 mRNA CTD PMID:29633893 diarsenic trioxide affects response to substance EXP 6480464 MAP2K3 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 dibutyl phthalate decreases expression ISO Map2k3 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of MAP2K3 mRNA CTD PMID:21266533 diclofenac affects expression ISO MAP2K3 (Homo sapiens) 6480464 Diclofenac affects the expression of MAP2K3 mRNA CTD PMID:24752500 dicrotophos increases expression ISO MAP2K3 (Homo sapiens) 6480464 dicrotophos results in increased expression of MAP2K3 mRNA CTD PMID:28302478 dinophysistoxin 1 increases expression ISO MAP2K3 (Homo sapiens) 6480464 dinophysistoxin 1 results in increased expression of MAP2K3 mRNA CTD PMID:28939011 diquat increases expression EXP 6480464 Diquat results in increased expression of MAP2K3 mRNA CTD PMID:36851058 disulfiram multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP2K3 mRNA CTD PMID:24690739 doxorubicin affects activity ISO MAP2K3 (Homo sapiens) 6480464 Doxorubicin affects the activity of MAP2K3 protein CTD PMID:15870702 elemental selenium increases expression ISO MAP2K3 (Homo sapiens) 6480464 Selenium results in increased expression of MAP2K3 mRNA CTD PMID:19244175 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of MAP2K3 mRNA CTD PMID:35436446 ethanol increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Ethanol results in increased expression of MAP2K3 mRNA CTD PMID:20655511 ethanol affects expression EXP 6480464 Ethanol affects the expression of MAP2K3 mRNA CTD PMID:30319688 etoposide increases expression ISO MAP2K3 (Homo sapiens) 6480464 Etoposide results in increased expression of MAP2K3 mRNA CTD PMID:17374387 flutamide increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Flutamide results in increased expression of MAP2K3 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP2K3 mRNA CTD PMID:22206623 fulvestrant multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 MAP2K3 promotes the reaction [fulvestrant results in decreased expression of GJA1 protein] CTD PMID:29180066 gemcitabine increases phosphorylation ISO MAP2K3 (Homo sapiens) 6480464 Gemcitabine results in increased phosphorylation of MAP2K3 protein CTD PMID:15003513 genistein decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Genistein results in decreased expression of MAP2K3 mRNA CTD PMID:16705744 gentamycin decreases expression ISO Map2k3 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of MAP2K3 mRNA CTD PMID:22061828 glafenine decreases expression ISO Map2k3 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of MAP2K3 mRNA CTD PMID:24136188 glyphosate decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Glyphosate results in decreased expression of MAP2K3 mRNA CTD PMID:31295307 glyphosate increases expression ISO MAP2K3 (Homo sapiens) 6480464 Glyphosate results in increased expression of MAP2K3 mRNA CTD PMID:31295307 hydralazine multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of MAP2K3 mRNA CTD PMID:17183730 indometacin multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA CTD PMID:28628672 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MAP2K3 mRNA CTD PMID:36331819 ivermectin decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Ivermectin results in decreased expression of MAP2K3 protein CTD PMID:32959892 josamycin affects response to substance ISO MAP2K3 (Homo sapiens) 6480464 MAP2K3 protein affects the susceptibility to Josamycin CTD PMID:31915244 L-ascorbic acid multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K3 protein] CTD PMID:16407847 Licochalcone B increases expression ISO MAP2K3 (Homo sapiens) 6480464 licochalcone B results in increased expression of MAP2K3 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of MAP2K3 mRNA more ... CTD PMID:18209571 more ... lipopolysaccharide increases expression ISO MAP2K3 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of MAP2K3 mRNA CTD PMID:35811015 lipopolysaccharide increases activity EXP 6480464 Lipopolysaccharides results in increased activity of MAP2K3 protein CTD PMID:21291324 lipopolysaccharide multiple interactions EXP 6480464 IRAK2 protein promotes the reaction [Lipopolysaccharides results in increased activity of MAP2K3 protein] CTD PMID:21291324 LY294002 multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of MAP2K3 mRNA] CTD PMID:12710931 malathion decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Malathion results in decreased expression of MAP2K3 mRNA CTD PMID:32069766 manganese(II) chloride decreases methylation ISO MAP2K3 (Homo sapiens) 6480464 manganese chloride results in decreased methylation of MAP2K3 gene CTD PMID:27913844 metformin multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of MAP2K3 mRNA CTD PMID:29309887 methamphetamine increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of MAP2K3 mRNA CTD PMID:19564919 methapyrilene increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of MAP2K3 mRNA CTD PMID:30467583 methotrexate increases expression ISO MAP2K3 (Homo sapiens) 6480464 Methotrexate results in increased expression of MAP2K3 mRNA CTD PMID:21678067 methotrexate decreases expression ISO MAP2K3 (Homo sapiens) 6480464 Methotrexate results in decreased expression of MAP2K3 mRNA CTD PMID:24449571 methylisothiazolinone increases expression ISO MAP2K3 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MAP2K3 mRNA CTD PMID:31629900 monosodium L-glutamate decreases expression ISO Map2k3 (Rattus norvegicus) 6480464 Sodium Glutamate results in decreased expression of MAP2K3 mRNA CTD PMID:28954212 N-acetyl-L-cysteine multiple interactions ISO Map2k3 (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein] CTD PMID:18703135 N-acetyl-L-cysteine multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein] CTD PMID:18703135 N-methyl-4-phenylpyridinium multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of MAP2K3 mRNA] CTD PMID:12710931 N-nitrosodiethylamine multiple interactions ISO Map2k3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP2K3 mRNA CTD PMID:17602206 nefazodone increases expression ISO Map2k3 (Rattus norvegicus) 6480464 nefazodone results in increased expression of MAP2K3 mRNA CTD PMID:24136188 nickel dichloride multiple interactions EXP 6480464 GADD45A protein inhibits the reaction [nickel chloride results in increased activity of MAP2K3 protein] CTD PMID:23536762 nickel sulfate increases phosphorylation ISO Map2k3 (Rattus norvegicus) 6480464 nickel sulfate results in increased phosphorylation of MAP2K3 protein CTD PMID:29567110 nimesulide increases expression ISO Map2k3 (Rattus norvegicus) 6480464 nimesulide results in increased expression of MAP2K3 mRNA CTD PMID:24136188 Nonylphenol increases expression ISO MAP2K3 (Homo sapiens) 6480464 nonylphenol results in increased expression of MAP2K3 protein CTD PMID:24039973 obeticholic acid decreases expression ISO MAP2K3 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of MAP2K3 mRNA CTD PMID:27939613 okadaic acid increases expression ISO MAP2K3 (Homo sapiens) 6480464 Okadaic Acid results in increased expression of MAP2K3 mRNA CTD PMID:28939011 paclitaxel multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of MAP2K3 mRNA CTD PMID:29309887 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of MAP2K3 mRNA CTD PMID:17562736 paracetamol increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of MAP2K3 mRNA CTD PMID:33387578 paracetamol increases expression ISO MAP2K3 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MAP2K3 mRNA CTD PMID:29067470 paraquat decreases response to substance ISO Map2k3 (Rattus norvegicus) 6480464 MAP2K3 gene mutant form results in decreased susceptibility to Paraquat CTD PMID:17324951 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MAP2K3 mRNA CTD PMID:28012437 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of MAP2K3 mRNA CTD PMID:26300304 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MAP2K3 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MAP2K3 mRNA CTD PMID:36331819 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of MAP2K3 mRNA CTD PMID:20813756 and PMID:23811191 quercetin increases expression ISO MAP2K3 (Homo sapiens) 6480464 Quercetin results in increased expression of MAP2K3 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of MAP2K3 mRNA CTD PMID:19059307 resveratrol affects expression ISO Map2k3 (Rattus norvegicus) 6480464 resveratrol affects the expression of MAP2K3 mRNA CTD PMID:15748624 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MAP2K3 protein CTD PMID:25505154 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAP2K3 mRNA CTD PMID:35811015 selenium atom increases expression ISO MAP2K3 (Homo sapiens) 6480464 Selenium results in increased expression of MAP2K3 mRNA CTD PMID:19244175 senecionine increases expression EXP 6480464 senecionine results in increased expression of MAP2K3 protein CTD PMID:35357534 sevoflurane increases phosphorylation ISO MAP2K3 (Homo sapiens) 6480464 sevoflurane results in increased phosphorylation of MAP2K3 protein CTD PMID:18349187 silicon dioxide increases expression ISO MAP2K3 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of MAP2K3 mRNA and Silicon Dioxide results in increased expression of MAP2K3 mRNA CTD PMID:25351596 and PMID:25895662 sodium arsenite increases expression ISO MAP2K3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP2K3 mRNA CTD PMID:12760830 and PMID:34032870 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MAP2K3 mRNA CTD PMID:19822182 tamoxifen multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of MAP2K3 mRNA CTD PMID:19059307 tert-butyl hydroperoxide increases expression ISO MAP2K3 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of MAP2K3 mRNA CTD PMID:15336504 tert-butyl hydroperoxide increases phosphorylation ISO MAP2K3 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased phosphorylation of MAP2K3 protein CTD PMID:17003459 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAP2K3 mRNA CTD PMID:31919559 thioacetamide increases expression ISO Map2k3 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of MAP2K3 mRNA CTD PMID:34492290 tributylstannane decreases expression ISO MAP2K3 (Homo sapiens) 6480464 tributyltin results in decreased expression of MAP2K3 mRNA CTD PMID:27678064 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of MAP2K3 mRNA CTD PMID:19042947 triphenyl phosphate increases expression ISO Map2k3 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of MAP2K3 mRNA CTD PMID:30589522 urethane increases expression ISO MAP2K3 (Homo sapiens) 6480464 Urethane results in increased expression of MAP2K3 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of MAP2K3 mRNA CTD PMID:17183730 valproic acid decreases methylation ISO MAP2K3 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of MAP2K3 gene CTD PMID:29154799 valproic acid increases expression ISO MAP2K3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP2K3 mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO Map2k3 (Rattus norvegicus) 6480464 vinclozolin affects the expression of MAP2K3 mRNA CTD PMID:19015723 zinc atom multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAP2K3 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO MAP2K3 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAP2K3 mRNA CTD PMID:18593933